However, patients with neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis had normal orexin levels, suggesting that not all neurological conditions damage orexin neurons or reduce their ability to produce orexin peptides. Here, HCRT is linked to early-onset autosomal dominant Alzheimer disease.